Your browser doesn't support javascript.
loading
Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial.
Mignard, Claire; Maho-Vaillant, Maud; Golinski, Marie-Laure; Balayé, Pierre; Prost-Squarcioni, Catherine; Houivet, Estelle; Calbo, Sé Bastien; Labeille, Bruno; Picard-Dahan, Catherine; Konstantinou, Maria Polina; Chaby, Guillaume; Richard, Marie-Aleth; Bouaziz, Jean-David; Duvert-Lehembre, Sophie; Delaporte, Emmanuel; Bernard, Philippe; Caux, Frédéric; Alexandre, Marina; Ingen-Housz-Oro, Saskia; Vabres, Pierre; Quereux, Gaëlle; Dupuy, Alain; Debarbieux, Sébastien; Avenel-Audran, Martine; D'Incan, Michel; Bédane, Christophe; Bénéton, Nathalie; Jullien, Denis; Dupin, Nicolas; Misery, Laurent; Machet, Laurent; Beylot-Barry, Marie; Dereure, Olivier; Sassolas, Bruno; Benichou, Jacques; Joly, Pascal; Hébert, Vivien.
Afiliação
  • Mignard C; Centre de référence des maladies bulleuses auto-immunes, Department of Dermatology, Rouen University Hospital, Normandie University, INSERM U1234, Rouen, France.
  • Maho-Vaillant M; Centre de référence des maladies bulleuses auto-immunes, Department of Dermatology, Rouen University Hospital, Normandie University, INSERM U1234, Rouen, France.
  • Golinski ML; Centre de référence des maladies bulleuses auto-immunes, Department of Dermatology, Rouen University Hospital, Normandie University, INSERM U1234, Rouen, France.
  • Balayé P; Department of Biostatistics and Clinical Research, Rouen University Hospital, Rouen, France.
  • Prost-Squarcioni C; Centre de référence des maladies bulleuses auto-immunes, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Department of Dermatology, University of Paris 13, Bobigny, France.
  • Houivet E; Department of Biostatistics and Clinical Research, Rouen University Hospital, Rouen, France.
  • Calbo SB; Centre de référence des maladies bulleuses auto-immunes, Department of Dermatology, Rouen University Hospital, Normandie University, INSERM U1234, Rouen, France.
  • Labeille B; Department of Dermatology, University of Saint Etienne, Saint Etienne, France.
  • Picard-Dahan C; Department of Dermatology, Bichat Hospital, University of Paris X, Paris, France.
  • Konstantinou MP; Department of Dermatology, University of Toulouse, Toulouse, France.
  • Chaby G; Department of Dermatology, University of Amiens, Amiens, France.
  • Richard MA; Assistance Publique des Hôpitaux de Marseille, Department of Dermatology, Aix Marseille University, UMR 911, INSERM CRO2, Marseille, France.
  • Bouaziz JD; Department of Dermatology, St Louis Hospital, Paris 7 Sorbonne Paris Cité University, Paris, France.
  • Duvert-Lehembre S; Department of Dermatology, University of Lille, Lille, France.
  • Delaporte E; Department of Dermatology, University of Lille, Lille, France.
  • Bernard P; Department of Dermatology, University of Reims, Reims, France.
  • Caux F; Centre de référence des maladies bulleuses auto-immunes, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Department of Dermatology, University of Paris 13, Bobigny, France.
  • Alexandre M; Centre de référence des maladies bulleuses auto-immunes, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Department of Dermatology, University of Paris 13, Bobigny, France.
  • Ingen-Housz-Oro S; Department of Dermatology, Assistance Publique-Hôpitaux de Paris, Henri Mondor Hospital, Créteil, France.
  • Vabres P; Department of Dermatology, Dijon University Hospital, Dijon, France.
  • Quereux G; Department of Dermatology, University of Nantes, Nantes, France.
  • Dupuy A; Department of Dermatology, University of Rennes, Rennes, France.
  • Debarbieux S; Department of Dermatology, Centre Hospitalier Lyon Sud, Pierre Bénite, Lyon, France.
  • Avenel-Audran M; Department of Dermatology, University of Angers, Angers, France.
  • D'Incan M; Department of Dermatology, University of Clermont-Ferrand, Clermont-Ferrand, France.
  • Bédane C; Department of Dermatology, University of Limoges, Limoges, France.
  • Bénéton N; Department of Dermatology, Le Mans General Hospital, Le Mans, France.
  • Jullien D; Department of Dermatology, Edouard Herriot Hospital, Lyon Claude Bernard University, Lyon, France.
  • Dupin N; Department of Dermatology, University of Paris V, Paris, France.
  • Misery L; Department of Dermatology, Brest University Hospital, Brest, France.
  • Machet L; Department of Dermatology, Tours University Hospital, Tours, France.
  • Beylot-Barry M; Department of Dermatology, University of Bordeaux, Bordeaux, France.
  • Dereure O; Department of Dermatology, University of Montpellier, Montpellier, France.
  • Sassolas B; Department of Internal Medicine, Brest University Hospital, Brest, France.
  • Benichou J; Department of Biostatistics and Clinical Research, Rouen University Hospital, Rouen, France.
  • Joly P; Centre de référence des maladies bulleuses auto-immunes, Department of Dermatology, Rouen University Hospital, Normandie University, INSERM U1234, Rouen, France.
  • Hébert V; Centre de référence des maladies bulleuses auto-immunes, Department of Dermatology, Rouen University Hospital, Normandie University, INSERM U1234, Rouen, France.
JAMA Dermatol ; 156(5): 545-552, 2020 05 01.
Article em En | MEDLINE | ID: mdl-32186656
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prednisona / Pênfigo / Rituximab / Fatores Imunológicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Dermatol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prednisona / Pênfigo / Rituximab / Fatores Imunológicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Dermatol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França